Clinical Trial Update: A Phase Ⅱ/Ⅲ Clinical Trial of RC148 Plus Chemotherapy as 1L Therapy for Unresectable or Metastatic Colorectal Cancer [Phase 2, Phase 3]

View source ↗

Summary

A Phase II/III clinical trial evaluating RC148 in combination with chemotherapy as first-line therapy for unresectable or metastatic colorectal cancer; the stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• RC148 (RC148)

Snippet

Sponsor: RemeGen Co., Ltd. | Conditions: Colorectal (Colon or Rectal) Cancer | Phase 2, Phase 3 | Status: NOT_YET_RECRUITING